Overexpression of KCNK5, KCNK9, and KCNK12, as well as reduced expression of KCNK6 and KCNK15, was significantly correlated with triple-negative subtype in breast carcinoma (Dookeran et al., 2017). Here, KCNK9 is linked to breast carcinoma.